Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Outcomes of Planned Conversion From Tacrolimus to Sirolimus-based Immunosuppressive Regimen in de Novo Kidney Transplant Recipients

NCT01802268 is registered in ClinicalTrials.gov with Helio Tedesco Silva Junior as lead sponsor.

NCT NCT01802268
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01802268 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Outcomes of Planned Conversion From Tacrolimus to Sirolimus-based Immunosuppressive Regimen in de Novo Kidney Transplant Recipients
Lead sponsor
Helio Tedesco Silva Junior
Phase
Phase 4
Overall status
Completed
Start date
February 29, 2008
Completion date
October 31, 2012
Enrollment
320 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant